z-logo
Premium
Nutritional management of patients with acute pancreatitis: a Dutch observational multicentre study
Author(s) -
SPANIER B. W. M.,
MATHUSVLIEGEN E. M. H.,
TUYNMAN H. A. R. E.,
VAN DER HULST R. W. M.,
DIJKGRAAF M. G. W.,
BRUNO M. J.
Publication year - 2008
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/j.1365-2036.2008.03814.x
Subject(s) - medicine , parenteral nutrition , regimen , enteral administration , acute pancreatitis , pancreatitis , observational study , starvation , gastroenterology , jejunum , surgery , pediatrics
Summary Background  Following a nil per os (NPO) regimen, most patients with acute pancreatitis (AP) can resume normal oral intake within 1 week. If not tolerated, it is recommended to initiate artificial feeding, preferably by the enteral route. Aim  To evaluate the nutritional management of patients with AP in a Dutch cohort (EARL study). Methods  Observational study in 18 hospitals. Total days of NPO, tube feeding (TF) with/without oral feeding, total parenteral nutrition (TPN) and total starvation time were analysed. Results  In mild AP, a majority of cases (80.7%, 117/145) were managed with an NPO regimen only. Twenty‐seven patients (18.6%) with mild AP additionally received TF; one received TPN. Of those with severe AP, more than half of the patients (56.2%, nine of 16) were treated with TF besides an NPO regimen; four received TPN. TF was delivered preferably via the jejunal route. The median period of total starvation was 2 days for both mild and severe AP. Only 5.5% (nine of 164) of patients had a prolonged starvation time of more than 5 days. Conclusions  The total time of starvation was limited in a majority of patients admitted for AP. According to international guidelines, additional nutritional interventions were quickly undertaken with enteral feeding via the jejunum as the preferred route.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here